𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of plasmid DNA from a pharmaceutical perspective

✍ Scribed by C. Russell Middaugh; Robert K. Evans; Donna L. Montgomery; Danilo R. Casimiro

Book ID
109388958
Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
178 KB
Volume
87
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Identifying stabilizers of plasmid DNA f
Identifying stabilizers of plasmid DNA for pharmaceutical use
✍ Yuhong Zeng; Joshua D. Ramsey; Robert King; Michael Leviten; Ruth Mcguire; David πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 452 KB

To better address the need for developing stable formulations of plasmid DNA-based biopharmaceuticals, 37 compounds from a generally regarded as safe library were examined for their potential use as stabilizers. A plasmid DNA-based therapeutic vaccine, BHT-DNA, was used as a model system. Initial st

Industrial Scale cGMP Purification of Ph
Industrial Scale cGMP Purification of Pharmaceutical Grade Plasmid-DNA
✍ J. Urthaler; W. Buchinger; R. Necina πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 339 KB

## Abstract The advances in gene therapy and genetic vaccination based on plasmid DNA result in an increasing demand of pharmaceutical grade plasmids produced under cGMP. A generic process consisting of a cell disintegration step followed by three different chromatography steps has been developed.